Enhanced	O
IGF	O
-	O
1	O
expression	O
improves	O
smooth	B-Cell
muscle	I-Cell
cell	I-Cell
engraftment	O
after	O
cell	B-Cell
transplantation	O
.	O

The	O
functional	O
benefit	O
of	O
cell	B-Cell
transplantation	O
after	O
a	O
myocardial	B-Multi-tissue_structure
infarction	O
is	O
diminished	O
by	O
early	O
cell	B-Cell
losses	O
.	O

IGF	O
-	O
1	O
enhances	O
cell	B-Cell
proliferation	O
and	O
survival	O
.	O

We	O
hypothesized	O
that	O
IGF	O
-	O
1	O
-	O
transfected	O
smooth	B-Cell
muscle	I-Cell
cells	I-Cell
(	O
SMCs	B-Cell
)	O
would	O
enhance	O
cell	B-Cell
survival	O
and	O
improve	O
engraftment	O
after	O
cell	B-Cell
transplantation	O
.	O

The	O
IGF	O
-	O
1	O
gene	O
was	O
transfected	O
into	O
male	O
SMCs	B-Cell
and	O
compared	O
with	O
SMCs	B-Cell
transfected	O
with	O
a	O
plasmid	B-Cellular_component
vector	O
(	O
vector	O
control	O
)	O
and	O
nontransfected	O
SMCs	B-Cell
(	O
cell	B-Cell
control	O
)	O
.	O

IGF	O
-	O
1	O
mRNA	O
(	O
n	O
=	O
10	O
/	O
group	O
)	O
and	O
protein	O
levels	O
(	O
n	O
=	O
6	O
/	O
group	O
)	O
were	O
higher	O
(	O
P	O
less	O
than	O
0	O
.	O
05	O
for	O
all	O
groups	O
)	O
at	O
3	O
,	O
7	O
,	O
and	O
14	O
days	O
compared	O
with	O
controls	O
.	O

VEGF	O
was	O
also	O
increased	O
in	O
parallel	O
to	O
enhanced	O
IGF	O
-	O
1	O
expression	O
.	O

IGF	O
-	O
1	O
-	O
transfected	O
cells	B-Cell
demonstrated	O
greater	O
cell	B-Cell
proliferation	O
,	O
stimulated	O
angiogenesis	O
,	O
and	O
decreased	O
caspase	O
-	O
3	O
activity	O
after	O
simulated	O
ischemia	O
and	O
reperfusion	O
(	O
P	O
less	O
than	O
0	O
.	O
05	O
for	O
all	O
groups	O
compared	O
with	O
vector	O
or	O
cell	B-Cell
controls	O
)	O
.	O

A	O
uniform	O
left	B-Multi-tissue_structure
ventricular	I-Multi-tissue_structure
injury	O
was	O
produced	O
in	O
female	O
rats	O
using	O
a	O
cryoprobe	O
.	O

Three	O
weeks	O
later	O
,	O
2	O
x	O
10	O
(	O
6	O
)	O
cells	B-Cell
from	O
three	O
groups	O
were	O
implanted	O
into	O
the	O
scar	B-Pathological_formation
.	O

One	O
week	O
later	O
,	O
IGF	O
-	O
1	O
-	O
transfected	O
SMCs	B-Cell
had	O
increased	O
myocardial	B-Multi-tissue_structure
IGF	O
-	O
1	O
and	O
VEGF	O
levels	O
,	O
increased	O
Bcl2	O
expression	O
,	O
limited	O
cell	B-Cell
apoptosis	O
,	O
and	O
enhanced	O
vessel	B-Multi-tissue_structure
formation	O
in	O
the	O
myocardial	B-Pathological_formation
scar	I-Pathological_formation
compared	O
with	O
the	O
two	O
control	O
groups	O
(	O
P	O
less	O
than	O
0	O
.	O
05	O
for	O
all	O
groups	O
)	O
.	O

The	O
proportion	O
of	O
SMCs	B-Cell
surviving	O
in	O
the	O
implanted	O
region	O
was	O
greater	O
(	O
P	O
less	O
than	O
0	O
.	O
05	O
)	O
in	O
the	O
IGF	O
-	O
1	O
-	O
transfected	O
group	O
than	O
in	O
the	O
vector	O
or	O
cell	B-Cell
controls	O
.	O

Gene	O
enhancement	O
with	O
IGF	O
-	O
1	O
improved	O
donor	B-Cell
cell	I-Cell
proliferation	O
,	O
survival	O
,	O
and	O
engraftment	O
after	O
cell	B-Cell
transplantation	O
,	O
perhaps	O
mediated	O
by	O
enhanced	O
angiogenesis	O
and	O
reduced	O
apoptosis	O
.	O

